First Time Loading...

MedPlus Health Services Ltd
NSE:MEDPLUS

Watchlist Manager
MedPlus Health Services Ltd Logo
MedPlus Health Services Ltd
NSE:MEDPLUS
Watchlist
Price: 703.65 INR -0.04% Market Closed
Updated: Jun 8, 2024
Section:
 

Relative Value

The Relative Value of one MEDPLUS stock under the Base Case scenario is 1 389.86 INR. Compared to the current market price of 703.65 INR, MedPlus Health Services Ltd is Undervalued by 49%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MEDPLUS Relative Value
Base Case
1 389.86 INR
Undervaluation 49%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1.5
P/S
P/S
Price to Sales
1.5
vs History
87
vs Industry
18
Median 3Y
1.9
Median 5Y
1.9
Industry
0.6
Forward
1.2
More Details
128.3
P/E
P/E
Price to Earnings
128.3
vs History
59
vs Industry
2
Median 3Y
146.2
Median 5Y
146.2
Industry
16.3
Forward
73.1
More Details
58.4
P/OCF
P/OCF
Price to OCF
58.4
vs History
68
vs Industry
3
Median 3Y
79
Median 5Y
79
Industry
7.8
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-46
Median 5Y
-46
Industry
15.6
More Details
5.5
P/B
P/B
Price to Book Value
5.5
vs History
65
vs Industry
10
Median 3Y
6
Median 5Y
6
Industry
1.6
More Details
1.6
EV/S
EV/S
Enterprise Value to Sales
1.6
vs History
87
vs Industry
18
Median 3Y
1.9
Median 5Y
1.9
Industry
0.7
Forward
1.3
More Details
7.3
EV/GP
EV/GP
Enterprise Value to Gross Profit
7.3
vs History
87
vs Industry
12
Median 3Y
9
Median 5Y
9
Industry
2.2
More Details
25.5
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
25.5
vs History
87
vs Industry
9
Median 3Y
33.2
Median 5Y
33.2
Industry
8.4
Forward
18.6
More Details
69.4
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
69.4
vs History
65
vs Industry
4
Median 3Y
84.3
Median 5Y
84.3
Industry
12.8
Forward
38.9
More Details
62.7
EV/OCF
EV/OCF
Enterprise Value to OCF
62.7
vs History
65
vs Industry
4
Median 3Y
84.7
Median 5Y
84.7
Industry
8.8
More Details
151.9
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
151.9
vs History
21
vs Industry
2
Median 3Y
-90
Median 5Y
-90
Industry
12.3
More Details
3.7
EV/IC
EV/IC
Enterprise Value to IC
3.7
vs History
78
vs Industry
9
Median 3Y
4.2
Median 5Y
4.2
Industry
1.1
More Details

Multiples Across Competitors

MEDPLUS Competitors Multiples
MedPlus Health Services Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
MedPlus Health Services Ltd
NSE:MEDPLUS
84B INR 1.5 128.3 25.5 69.4
ZA
Clicks Group Ltd
JSE:CLS
73.3B Zac 0 0 0 0
ZA
Dis-Chem Pharmacies Ltd
JSE:DCP
27.5B Zac 0 0 0 0
US
Walgreens Boots Alliance Inc
NASDAQ:WBA
13.7B USD 0.1 -2.3 4.9 10.9
BR
Raia Drogasil SA
BOVESPA:RADL3
43.4B BRL 1.2 41.3 12.1 21.4
JP
MatsukiyoCocokara & Co
TSE:3088
894.8B JPY 0.9 17.1 7.9 10.3
CN
Yifeng Pharmacy Chain Co Ltd
SSE:603939
35.3B CNY 1.5 23.8 18.5 18.5
MX
Corporativo Fragua SAB de CV
BMV:FRAGUAB
82.4B MXN 0.7 17.1 7.8 9.3
SA
Al Nahdi Medical Company SCJSC
SAU:4164
17.1B SAR 1.9 19.4 11 18.4
JP
Cosmos Pharmaceutical Corp
TSE:3349
501.9B JPY 0.5 20.2 9.8 15.5
CN
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
22.1B CNY 0.9 20.7 16.9 16.9

See Also

Summary
MEDPLUS intrinsic value, competitors valuation, and company profile.
DCF Valuation
MEDPLUS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MEDPLUS stock valuation using valuation multiples.
Wall Street Estimates
MEDPLUS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MEDPLUS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 145,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.